{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:53:29Z","timestamp":1792205609869,"version":"4.4.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.diagmicrobio.2026.117459","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:28:01Z","timestamp":1778628481000},"page":"117459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Streptococcus pneumoniae: Pathogenesis, virulence factors, antimicrobial resistance mechanisms, and therapeutic strategies"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-0311","authenticated-orcid":false,"given":"Geoffrey E.","family":"Woodard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0002","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0003","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0004","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","article-title":"Interim results of an ecological experiment - conjugate vaccination against the pneumococcus and serotype replacement","volume":"12","author":"Hausdorff","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"9807","key":"10.1016\/j.diagmicrobio.2026.117459_bib0006","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0007","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1073\/pnas.0511017103","article-title":"A pneumococcal pilus influences virulence and host inflammatory responses","volume":"103","author":"Barocchi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/IAI.01475-06","article-title":"Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance","volume":"75","author":"Nelson","year":"2007","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mib.2016.11.003","article-title":"Viral-bacterial co-infections in the respiratory tract","volume":"35","author":"Bakaletz","year":"2017","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0011","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0012","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"6548","key":"10.1016\/j.diagmicrobio.2026.117459_bib0013","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/377435a0","article-title":"Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor","volume":"377","author":"Cundell","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1172\/JCI2406","article-title":"Pneumococcal trafficking across the blood-brain barrier","volume":"102","author":"Ring","year":"1998","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/IAI.00881-09","article-title":"The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0016","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0017","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0020","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pgen.0020031","article-title":"Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes","volume":"2","author":"Bentley","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0021","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.micro.62.081307.162944","article-title":"Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation","volume":"65","author":"Yother","year":"2011","journal-title":"Annu Rev Microbiol"},{"issue":"21","key":"10.1016\/j.diagmicrobio.2026.117459_bib0022","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JB.00837-07","article-title":"Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci","volume":"189","author":"Aanensen","year":"2007","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/514205","article-title":"Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae","volume":"177","author":"Kim","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0024","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/IAI.01056-09","article-title":"Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/srep30176","article-title":"Allelic variation of the capsule promoter diversifies encapsulation and virulence in Streptococcus pneumoniae","volume":"6","author":"Wen","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0026","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0027","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0028","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-94-017-8881-6_8","article-title":"The biology of pneumolysin","volume":"80","author":"Mitchell","year":"2014","journal-title":"Subcell Biochem"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0029","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2005.02.033","article-title":"Structural basis of pore formation by the bacterial toxin pneumolysin","volume":"121","author":"Tilley","year":"2005","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0030","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/iai.57.7.2006-2013.1989","article-title":"Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro","volume":"57","author":"Steinfort","year":"1989","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0031","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/iai.41.3.1212-1216.1983","article-title":"Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin","volume":"41","author":"Paton","year":"1983","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0032","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/iai.57.7.2037-2042.1989","article-title":"Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae","volume":"57","author":"Berry","year":"1989","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/172.1.119","article-title":"The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus","volume":"172","author":"Canvin","year":"1995","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117459_bib0034","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"Hollingshead","year":"2000","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0035","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1128\/IAI.00940-07","article-title":"Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition","volume":"75","author":"Darrieux","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0036","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/IAI.72.1.114-122.2004","article-title":"Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface","volume":"72","author":"Ren","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0037","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/IAI.69.5.3372-3381.2001","article-title":"Characterization of binding of human lactoferrin to pneumococcal surface protein A","volume":"69","author":"Hakansson","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0038","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117459_bib0039","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/CVI.00395-08","article-title":"Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice","volume":"16","author":"Ferreira","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"31","key":"10.1016\/j.diagmicrobio.2026.117459_bib0040","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1073\/pnas.0705589104","article-title":"Clonal success of piliated penicillin nonsusceptible pneumococci","volume":"104","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2180-8-41","article-title":"The presence of the pilus locus is a clonal property among pneumococcal invasive isolates","volume":"8","author":"Aguiar","year":"2008","journal-title":"BMC Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0042","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/IAI.74.4.2453-2456.2006","article-title":"RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet","volume":"74","author":"LeMieux","year":"2006","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000026","article-title":"Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A","volume":"4","author":"Hilleringmann","year":"2008","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0044","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2958.2008.06396.x","article-title":"Sortase-mediated assembly and surface topology of adhesive pneumococcal pili","volume":"70","author":"F\u00e4lker","year":"2008","journal-title":"Mol Microbiol"},{"issue":"24","key":"10.1016\/j.diagmicrobio.2026.117459_bib0045","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/emboj.2009.360","article-title":"Molecular architecture of Streptococcus pneumoniae TIGR4 pili","volume":"28","author":"Hilleringmann","year":"2009","journal-title":"EMBO J"},{"issue":"5856","key":"10.1016\/j.diagmicrobio.2026.117459_bib0046","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1145806","article-title":"Stabilizing isopeptide bonds revealed in gram-positive bacterial pilus structure","volume":"318","author":"Kang","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0047","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.str.2009.10.019","article-title":"Structural basis of host cell recognition by the pilus adhesin from Streptococcus pneumoniae","volume":"18","author":"Izore","year":"2010","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0048","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/IAI.01400-06","article-title":"Streptococcus pneumoniae pilus subunits protect mice against lethal challenge","volume":"75","author":"Gianfaldoni","year":"2007","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0049","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.str.2008.10.007","article-title":"Sortase-mediated pilus fiber biogenesis in Streptococcus pneumoniae","volume":"16","author":"Manzano","year":"2008","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2958.2006.05279.x","article-title":"Pili with strong attachments: Gram-positive bacteria do it differently","volume":"62","author":"Scott","year":"2006","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0051","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2958.2007.05908.x","article-title":"RrgA is a pilus-associated adhesin in Streptococcus pneumoniae","volume":"66","author":"Nelson","year":"2007","journal-title":"Mol Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0052","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1172\/JCI84705","article-title":"Henriques-Normark B. Pneumococcal meningitis is promoted by single cocci expressing pilus adhesin RrgA","volume":"126","author":"Iovino","year":"2016","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0053","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00535-12","article-title":"Pilus adhesin RrgA interacts with complement receptor 3, thereby affecting macrophage function and systemic pneumococcal disease","volume":"4","author":"Orrskog","year":"2013","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0054","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1084\/jem.20060482","article-title":"Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier","volume":"203","author":"Mairey","year":"2006","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0055","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/IAI.00054-08","article-title":"Convergence of regulatory networks on the pilus locus of Streptococcus pneumoniae","volume":"76","author":"Rosch","year":"2008","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0056","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1073\/pnas.0511017103","article-title":"A pneumococcal pilus influences virulence and host inflammatory responses","volume":"103","author":"Barocchi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2026.117459_bib0057","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JB.00384-08","article-title":"A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells","volume":"190","author":"Bagnoli","year":"2008","journal-title":"J Bacteriol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0058","article-title":"Mitis group streptococci express variable pilus islet 2 pili","volume":"6","author":"Z\u00e4hner","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0059","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/IAI.05117-11","article-title":"Expression of the type 1 pneumococcal pilus is bistable and negatively regulated by the structural component RrgA","volume":"79","author":"Basset","year":"2011","journal-title":"Infect Immun"},{"issue":"Suppl 4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0060","first-page":"D18","article-title":"Increase in pilus expression in Streptococcus pneumoniae is associated with disease","volume":"28","author":"Z\u00e4hner","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0061","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.vaccine.2011.12.080","article-title":"Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations","volume":"30","author":"Moschioni","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0062","first-page":"4572","article-title":"Pilus vaccine antigen RrgA in the pneumococcus: implications for future vaccine development","volume":"83","author":"Young","year":"2015","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0063","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antibiotics5020021","article-title":"Choline binding proteins from Streptococcus pneumoniae: a dual role as enzybiotics and targets for the design of new antimicrobials","volume":"5","author":"Maestro","year":"2016","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117459_bib0064","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2958.1997.mmi494.x","article-title":"Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae","volume":"25","author":"Rosenow","year":"1997","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.68.2.921-924.2000","article-title":"Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model","volume":"68","author":"Tong","year":"2000","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0066","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1073\/pnas.0637469100","article-title":"Antibody-enhanced pneumococcal adherence requires IgA1 protease","volume":"100","author":"Weiser","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0378-1119(90)90116-9","article-title":"Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages","volume":"86","author":"Garcia","year":"1990","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0068","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2958.2001.02414.x","article-title":"A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence","volume":"40","author":"Brown","year":"2001","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0069","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/IAI.68.7.3990-3997.2000","article-title":"Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract","volume":"68","author":"Pericone","year":"2000","journal-title":"Infect Immun"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2026.117459_bib0070","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0071","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0072","first-page":"1505","article-title":"Pneumococcal polysaccharide vaccines: a historical perspective","volume":"8","author":"Grabenstein","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0073","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0074","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0076","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0077","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"10.1016\/j.diagmicrobio.2026.117459_bib0078","first-page":"3793","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) compared to PCV13 in healthy infants","volume":"36","author":"Greenberg","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117459_bib0079","first-page":"2351","article-title":"Phase 3 trial of a 21-valent pneumococcal conjugate vaccine in healthy adults aged 18-49 years","volume":"42","author":"Thompson","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117459_bib0080","first-page":"1668","article-title":"The epidemiology and multidrug resistance of Streptococcus pneumoniae serotype 15C and 35B","volume":"41","author":"Grant","year":"2023","journal-title":"Vaccine"},{"issue":"9807","key":"10.1016\/j.diagmicrobio.2026.117459_bib0081","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117459_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0083","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0084","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0085","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3201\/eid2306.170071","article-title":"Invasive serotype 35B pneumococci including an expanding serotype switch lineage, United States, 2015-2016","volume":"23","author":"Chochua","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0086","first-page":"1070","article-title":"Reemergence of pneumococcal disease in southwest Alaska","volume":"217","author":"Bruce","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220453","article-title":"Limited indirect effects of an infant pneumococcal vaccination program in an aging population","volume":"14","author":"van der Linden","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0088","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0089","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0090","first-page":"115","article-title":"Escaping conventional paradigms in pneumococcal vaccine development","volume":"17","author":"Poolman","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0091","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"Moffitt","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0092","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/iai.62.12.5683-5688.1994","article-title":"Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae","volume":"62","author":"Alexander","year":"1994","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0093","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0094","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0095","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.vaccine.2011.12.080","article-title":"Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations","volume":"30","author":"Moschioni","year":"2012","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.diagmicrobio.2026.117459_bib0096","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1016\/j.vaccine.2015.06.078","article-title":"PnuBioVax-01 Study Group. Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine formulation in healthy adults","volume":"33","author":"Brooks","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0097","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/erv.12.5","article-title":"Issues and challenges in the development of pneumococcal protein vaccines","volume":"11","author":"Ginsburg","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0098","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0099","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/ofid\/ofy263","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016)","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0100","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1471-2180-10-299","article-title":"Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008","volume":"10","author":"Im\u00f6hl","year":"2010","journal-title":"BMC Microbiol"},{"issue":"37","key":"10.1016\/j.diagmicrobio.2026.117459_bib0102","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2009.05.037","article-title":"Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France","volume":"28","author":"Cohen","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/fmb.12.2","article-title":"Molecular mechanisms of beta-lactam resistance in Streptococcus pneumoniae","volume":"7","author":"Hakenbeck","year":"2012","journal-title":"Future Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0104","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/AAC.18.4.629","article-title":"In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae","volume":"18","author":"Williamson","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"10.1016\/j.diagmicrobio.2026.117459_bib0105","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1073\/pnas.86.22.8842","article-title":"Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae","volume":"86","author":"Dowson","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0106","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2958.1993.tb01723.x","article-title":"Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae","volume":"9","author":"Dowson","year":"1993","journal-title":"Mol Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0107","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/IAI.69.4.2477-2486.2001","article-title":"Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae","volume":"69","author":"Hakenbeck","year":"2001","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.diagmicrobio.2026.117459_bib0108","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1128\/jb.173.21.6986-6990.1991","article-title":"Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae","volume":"173","author":"Laible","year":"1991","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0109","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/AAC.40.4.829","article-title":"Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics","volume":"40","author":"Grebe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0110","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1073\/pnas.032671699","article-title":"The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae","volume":"99","author":"Filipe","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0111","series-title":"Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing","year":"2018"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0112","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0113","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0114","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/315853","article-title":"The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment","volume":"182","author":"Gay","year":"2000","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/mdr.1998.4.325","article-title":"Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States","volume":"4","author":"Corso","year":"1998","journal-title":"Microb Drug Resist"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0117","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/fmb.12.63","article-title":"Acquired inducible antimicrobial resistance in Gram-positive bacteria","volume":"7","author":"Chancey","year":"2012","journal-title":"Future Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117459_bib0118","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.41.10.2251","article-title":"mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae","volume":"41","author":"Tait-Kamradt","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117459_bib0119","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1128\/AAC.49.10.4203-4209.2005","article-title":"Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible","volume":"49","author":"Ambrose","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/321001","article-title":"Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae","volume":"184","author":"Gay","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0121","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0122","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00598-07","article-title":"The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271","volume":"51","author":"Del Grosso","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0123","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fmicb.2019.00868","article-title":"High-level macrolide resistance due to the mega element [mef(E)\/mel] in Streptococcus pneumoniae","volume":"10","author":"Schroeder","year":"2019","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0124","first-page":"377","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0125","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0126","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1128\/AAC.40.11.2505","article-title":"Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro","volume":"40","author":"Tankovic","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0127","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/AAC.42.11.2810","article-title":"DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae","volume":"42","author":"Pan","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0128","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.40.12.2760","article-title":"High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA","volume":"40","author":"Janoir","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0129","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.00731-07","article-title":"Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes","volume":"52","author":"Balsalobre","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/AAC.50.2.685-693.2006","article-title":"Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae","volume":"50","author":"Marrer","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0132","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/321841","article-title":"Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies","volume":"33","author":"Zhao","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0133","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","article-title":"Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants","volume":"43","author":"Roberts","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117459_bib0134","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/S0021-9258(18)49928-0","article-title":"Purification and characterization of Tet(M), a protein that renders ribosomes resistant to tetracycline","volume":"266","author":"Burdett","year":"1991","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0135","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.44.11.2979-2984.2000","article-title":"Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae","volume":"44","author":"Doherty","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0136","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2011-12-11-r115","article-title":"Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease","volume":"12","author":"Fani","year":"2011","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0137","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/jac\/dkv060","article-title":"Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing","volume":"70","author":"Lupien","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117459_bib0138","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1128\/AAC.41.10.2121","article-title":"Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae","volume":"41","author":"Maskell","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0139","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/AAC.41.11.2406","article-title":"Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae","volume":"41","author":"Adrian","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","article-title":"Pneumococcal resistance to antibiotics","volume":"3","author":"Klugman","year":"1990","journal-title":"Clin Microbiol Rev"},{"issue":"Pt 11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0141","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0142","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":"High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0143","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the United States","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PLoS Pathog"},{"issue":"6016","key":"10.1016\/j.diagmicrobio.2026.117459_bib0144","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1198545","article-title":"Rapid pneumococcal evolution in response to clinical interventions","volume":"331","author":"Croucher","year":"2011","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0145","doi-asserted-by":"crossref","first-page":"i23","DOI":"10.1093\/jac\/dkab352","article-title":"Current and future perspectives in the treatment of multidrug-resistant Gram-positive infections","volume":"76","author":"Bassetti","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0146","first-page":"217","article-title":"Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0147","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/00003495-200969070-00003","article-title":"Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus","volume":"69","author":"Zhanel","year":"2009","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0148","first-page":"116","article-title":"Antimicrobial activity of ceftaroline tested against bacterial isolates causing community-acquired pneumonia and skin and skin structure infections in Latin American medical centres: results from the AWARE surveillance program","volume":"44","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0149","first-page":"2844","article-title":"Antimicrobial activity of ceftaroline tested against Streptococcus pneumoniae with various macrolide resistance mechanisms","volume":"57","author":"Farrell","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0150","article-title":"FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia","volume":"66","author":"Jr","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0151","first-page":"2558","article-title":"Summary of ceftaroline activity against Streptococcus pneumoniae from seven years of a global surveillance program (2008-2014)","volume":"60","author":"Mendes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0152","first-page":"182","article-title":"The pleuromutilin antibiotics: a new class for human use","volume":"11","author":"Novak","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117459_bib0153","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02380-17","article-title":"Antimicrobial activity of lefamulin against sexually transmitted bacterial pathogens","volume":"62","author":"Paukner","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0154","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/cid\/ciz090","article-title":"Efficacy and safety of intravenous-to-oral lefamulin, a pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia: the Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) trial","volume":"69","author":"Jr","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.diagmicrobio.2026.117459_bib0155","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2019.15468","article-title":"Oral lefamulin vs moxifloxacin for early clinical response among adults with community-acquired bacterial pneumonia: the LEAP 2 randomized clinical trial","volume":"322","author":"Alexander","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117459_bib0156","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/jac\/dks001","article-title":"Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)","volume":"67","author":"Sader","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0157","article-title":"In vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0158","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/AAC.01066-13","article-title":"Mechanism of action of the novel aminomethylcycline antibiotic omadacycline","volume":"58","author":"Draper","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0159","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa1800201","article-title":"Omadacycline for community-acquired bacterial pneumonia","volume":"380","author":"Stets","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0161","first-page":"1305","article-title":"Antimicrobial activity of omadacycline tested against clinical isolates from the United States and Europe: results from the SENTRY Antimicrobial Surveillance Program, 2017","volume":"38","author":"Sader","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0162","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.01201-10","article-title":"Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-Gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus","volume":"55","author":"Lemaire","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0163","article-title":"In vitro activities of delafloxacin and other fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis","volume":"63","author":"Waites","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0164","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acsinfecdis.8b00315","article-title":"Osheroff N. Mechanistic and structural basis for the actions of the antibacterial gepotidacin against Staphylococcus aureus gyrase","volume":"5","author":"Gibson","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/cid\/ciw490","article-title":"SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia","volume":"63","author":"File","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117459_bib0166","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/AAC.00060-10","article-title":"Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa by using cefepime, ceftazidime, or ceftobiprole","volume":"54","author":"Queenan","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0167","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0168","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010215","article-title":"The pneumococcus: epidemiology, microbiology, and pathogenesis","volume":"3","author":"Henriques-Normark","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0169","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117459_bib0171","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ng.2625","article-title":"Population genomics of post-vaccine changes in pneumococcal epidemiology","volume":"45","author":"Croucher","year":"2013","journal-title":"Nat Genet"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0172","doi-asserted-by":"crossref","first-page":"C43","DOI":"10.1016\/j.vaccine.2011.07.047","article-title":"The future of pneumococcal disease prevention","volume":"29","author":"Rodgers","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117459_bib0173","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng.2895","article-title":"Dense genomic sampling identifies highways of pneumococcal recombination","volume":"46","author":"Chewapreecha","year":"2014","journal-title":"Nat Genet"},{"issue":"9693","key":"10.1016\/j.diagmicrobio.2026.117459_bib0174","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm1077","article-title":"Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0176","first-page":"404","article-title":"Efficacy and safety of a 10-valent pneumococcal conjugate vaccine in Bangladeshi infants","volume":"36","author":"Zaman","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"34","key":"10.1016\/j.diagmicrobio.2026.117459_bib0177","doi-asserted-by":"crossref","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117459_bib0178","first-page":"103","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and involvement of pneumococcal surface protein A","volume":"32","author":"Pletz","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0179","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"4 Suppl","key":"10.1016\/j.diagmicrobio.2026.117459_bib0180","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0181","first-page":"1732","article-title":"Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in sub-Saharan Africa","volume":"48","author":"Deloria Knoll","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2026.117459_bib0182","first-page":"667","article-title":"Comparison of pneumococcal serotypes identified in invasive disease isolates and nasopharyngeal carriage isolates from children in Spain","volume":"30","author":"Sanz","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117459_bib0183","first-page":"1038","article-title":"Invasive pneumococcal disease in hospitalized children: a review of 223 cases in Australian children","volume":"96","author":"Skull","year":"2007","journal-title":"Acta Paediatr"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117459_bib0184","doi-asserted-by":"crossref","first-page":"1002.e1","DOI":"10.1016\/j.cmi.2016.08.001","article-title":"Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus pneumoniae in the United States","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0185","first-page":"431","article-title":"Serotype-associated differences in penicillin binding protein 2b and 2x sequences among clinical isolates of Streptococcus pneumoniae","volume":"47","author":"McGee","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117459_bib0186","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2012.08.024","article-title":"Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the AWARE Surveillance Program","volume":"75","author":"Jones","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3 Suppl","key":"10.1016\/j.diagmicrobio.2026.117459_bib0187","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2008.09.suppl52.280","article-title":"Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0188","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of 'bug and drug","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"17","key":"10.1016\/j.diagmicrobio.2026.117459_bib0189","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in sub-Saharan Africa","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2026.117459_bib0190","first-page":"252","article-title":"Impact of mass azithromycin distribution on antibiotic resistance in Streptococcus pneumoniae nasopharyngeal carriage: a systematic review","volume":"106","author":"Haile-Selassie","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117459_bib0191","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117459_bib0192","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326002099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326002099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:36:33Z","timestamp":1780310193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326002099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":192,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0732889326002099"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117459","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Streptococcus pneumoniae: Pathogenesis, virulence factors, antimicrobial resistance mechanisms, and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117459"}}